***Background.*** The incidence of CDI is increasing. CDI had occurred primarily among hospitalized adults. However, recent data suggests CDI has spread to the community and to children.

***Methods.*** The incidence of CDI was calculated among the Medicaid population of New York State between 2006 and 2012. The population approximated 5 million annually. Sixty-two percent of the members were adults and 38% were children. The incidence use of antibiotics, protein pump inhibitors (PPI) and histamine 2 receptor blockers (H2B) were calculated as well. The following age groups were compared: 65 years and older, 19-64 years, 1-18 years and children \<1 year old. Children \< 1 year old were excluded from CDI calculations and included in drug use calculations.

***Results.*** Incidence of CDI for the total population increased from 0.13% to 0.32% from 2006 through 2012. The incidence for the 65 years and older group increased from 0.28%, peaked at 0.54% in 2011 and declined to 0.51%. The incidence for the 19-64 years group rose from 0.11% to 0.29%. The incidence for the 1-18 years group rose from 0.01% to 0.06%. The incidence use of antibiotics of 24.66% exceeded the incidence use of PPI of 6.9 % and H2B of 2.47% for the total population. The 1-18 years group had the highest incidence use of antibiotics of 35.39%. The 19-64 years group had the highest incidence use of PPI of 12.2%. The age group \< 1 year had the highest incidence use of H2B of 4.30%. The use of 2 or 3 drug classes in a single year was significantly more common in CDI-positive versus CDI-negative subjects regardless of age; the same relationship was not seen for 1 or no drug use.

***Conclusion.*** The incidence of community-associated CDI rose over 8 years. Although adults had the highest rates, the rate of change was highest among children. Concurrent age-related changes in the use of antibiotics, PPI and H2B may have impacted on CDI rates.
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